These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9476267)

  • 61. The many faces of TNF in arthritis.
    McHugh J
    Nat Rev Rheumatol; 2020 Nov; 16(11):603. PubMed ID: 32873969
    [No Abstract]   [Full Text] [Related]  

  • 62. Rheumatoid Arthritis: Sirukumab effective in patients refractory to anti-TNF therapy.
    McHugh J
    Nat Rev Rheumatol; 2017 Apr; 13(4):197. PubMed ID: 28250460
    [No Abstract]   [Full Text] [Related]  

  • 63. Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.
    Sieberts SK; Zhu F; García-García J; Stahl E; Pratap A; Pandey G; Pappas D; Aguilar D; Anton B; Bonet J; Eksi R; Fornés O; Guney E; Li H; Marín MA; Panwar B; Planas-Iglesias J; Poglayen D; Cui J; Falcao AO; Suver C; Hoff B; Balagurusamy VSK; Dillenberger D; Neto EC; Norman T; Aittokallio T; Ammad-Ud-Din M; Azencott CA; Bellón V; Boeva V; Bunte K; Chheda H; Cheng L; Corander J; Dumontier M; Goldenberg A; Gopalacharyulu P; Hajiloo M; Hidru D; Jaiswal A; Kaski S; Khalfaoui B; Khan SA; Kramer ER; Marttinen P; Mezlini AM; Molparia B; Pirinen M; Saarela J; Samwald M; Stoven V; Tang H; Tang J; Torkamani A; Vert JP; Wang B; Wang T; Wennerberg K; Wineinger NE; Xiao G; Xie Y; Yeung R; Zhan X; Zhao C; ; Greenberg J; Kremer J; Michaud K; Barton A; Coenen M; Mariette X; Miceli C; Shadick N; Weinblatt M; de Vries N; Tak PP; Gerlag D; Huizinga TWJ; Kurreeman F; Allaart CF; Bridges SL; Criswell L; Moreland L; Klareskog L; Saevarsdottir S; Padyukov L; Gregersen PK; Friend S; Plenge R; Stolovitzky G; Oliva B; Guan Y; Mangravite LM
    Nat Commun; 2016 Oct; 7():13205. PubMed ID: 27721464
    [No Abstract]   [Full Text] [Related]  

  • 64. Introducing RMD Open.
    Cutolo M; Burmester GR; Kvien TK
    RMD Open; 2015; 1(1):e000031. PubMed ID: 26509059
    [No Abstract]   [Full Text] [Related]  

  • 65. Case report: Pentoxifylline treatment in microscopic colitis.
    Cotter TG; Kamboj AK; Hicks SB; Tremaine WJ; Loftus EV; Pardi DS
    Medicine (Baltimore); 2017 Nov; 96(46):e8355. PubMed ID: 29145246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological studies on the anti-inflammatory and immunomodulatory role of pentoxifylline and its interaction with nitric oxide (NO) in experimental arthritis in rats.
    Pal R; Chaudhary MJ; Tiwari PC; Nath R; Babu S; Pant KK
    Inflammopharmacology; 2016 Oct; 24(5):221-231. PubMed ID: 27671331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Expert Opin Investig Drugs; 2008 Apr; 17(4):451-67. PubMed ID: 18363512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
    Cunha JM; Cunha FQ; Poole S; Ferreira SH
    Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.
    Maksymowych WP; Avina-Zubieta A; Luong MH; Russell AS
    J Rheumatol; 1995 Apr; 22(4):625-9. PubMed ID: 7791152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis.
    Dubost JJ; Soubrier M; Ristori JM; Beaujon G; Oualid T; Bussière JL; Sauvezie B
    Rev Rhum Engl Ed; 1997 Dec; 64(12):789-93. PubMed ID: 9476267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.
    Anaya JM; Espinoza LR
    J Rheumatol; 1995 Apr; 22(4):595-9. PubMed ID: 7791149
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.